| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |